Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial
- PMID: 33408027
- PMCID: PMC7779261
- DOI: 10.1016/j.ijantimicag.2020.106237
Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial
Comment on
-
Effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.Int J Antimicrob Agents. 2021 Jan;57(1):106172. doi: 10.1016/j.ijantimicag.2020.106172. Int J Antimicrob Agents. 2021. PMID: 33408017 Free PMC article. No abstract available.
Similar articles
-
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.N Engl J Med. 2021 Feb 4;384(5):417-427. doi: 10.1056/NEJMoa2021801. Epub 2020 Nov 24. N Engl J Med. 2021. PMID: 33289973 Free PMC article. Clinical Trial.
-
Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.Trials. 2020 Jul 8;21(1):631. doi: 10.1186/s13063-020-04566-x. Trials. 2020. PMID: 32641163 Free PMC article.
-
Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.J Antimicrob Chemother. 2021 Jan 1;76(1):276-277. doi: 10.1093/jac/dkaa327. J Antimicrob Chemother. 2021. PMID: 32766679 Free PMC article. No abstract available.
-
Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan.Trials. 2020 Oct 20;21(1):867. doi: 10.1186/s13063-020-04795-0. Trials. 2020. PMID: 33081817 Free PMC article. Clinical Trial.
-
COVID-19 Pneumonia during Hydroxychloroquine Treatment of Rheumatoid Arthritis.J Coll Physicians Surg Pak. 2020 Oct;30(10):168-170. doi: 10.29271/jcpsp.2020.supp2.S168. J Coll Physicians Surg Pak. 2020. PMID: 33291197
Cited by
-
Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann.Int J Antimicrob Agents. 2021 Mar;57(3):106306. doi: 10.1016/j.ijantimicag.2021.106306. Epub 2021 Feb 14. Int J Antimicrob Agents. 2021. PMID: 33596459 Free PMC article. No abstract available.
References
-
- European Centre for Disease Prevention and Control. Guidance for discharge and ending isolation in the context of widespread community transmission of COVID-19 – first update. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-guidan... (Accessed 4 October, 2020)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical